DNA shuffling and screening strategies for improving vaccine efficacy

DNA and Cell Biology

Volumn 24, Issue 4, 2005, Pages 256-263

  Locher, Christopher P ^a   Paidhungat, Madan ^a   Whalen, Robert G ^a   Punnonen, Juha ^a  

^a MAXYGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOMODULATING AGENT; MALARIA VACCINE; VACCINE; VIRUS VACCINE;

ARTICLE; CHIMERA; CROSS REACTION; DNA SCREENING; DNA SHUFFLING; DRUG EFFICACY; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; GENETIC RECOMBINATION; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; MOLECULAR EVOLUTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SEROTYPE; T LYMPHOCYTE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANTIGENS; CROSS REACTIONS; DIRECTED MOLECULAR EVOLUTION; DNA SHUFFLING; GENETIC ENGINEERING; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

ALPHAVIRUS; DENGUE VIRUS; EASTERN EQUINE ENCEPHALITIS VIRUS; EQUIDAE; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PLASMODIUM FALCIPARUM; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS;

EID: 16844377999     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.256     Document Type: Article

References (55)

1. ABECASSIS, V., JAFFRELO, L., RICKMAN, D., AGGERBECK, L., HERBERT, C., TRUAN, G., and POMPON, D. (2003). Microarray-based method for combinatorial library sequence mapping and characterization. Biotechniques 34, 1272-1279.
2. APT, D., RAVIPRAKASH, K., BRINKMAN, A., SEMYONOV, A., YANG, S., SKINNER, C., DIEHL, L., LYONS, R., PORTER, K., and PUNNONEN, J. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric DNA vaccine. Submitted for publication.
3. ARNOLD, F.H., and GEORGIOU, G., ED. (2003). Directed evolution library creation, methods and protocols. In Methods in Molecular Biology, Vol. 231 (Humana Press, Totowa, NJ).
4. BARUCH, D.I., PASLOSKE, B.L., SINGH, H.B., BI, X., MA, X.C., FELDMAN, M., TARASCHI, T.F., and HOWARD, R.J. (1995). Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82, 77-87.
5. BARUCH, D.I., GAMAIN, B., BARNWELL, J.W., SULLIVAN, J.S., STOWERS, A., GALLAND, G.G., MILLER, L.H., and COLLINS, W.E. (2002). Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc. Natl. Acad. Sci. USA 99, 3860-3865.
6. BRAULT, A.C., POWERS, A.M., CHAVEZ, C.L., LOPEZ, R.N., CACHON, M.F., GUTIERREZ, L.F., KANG, W., TESH, R.B., SHOPE, R.E., and WEAVER, S.C. (1999). Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America. Am. J. Trop. Med. Hyg. 61, 579-586.
7. BULL, P.C., LOWE, B.S., KORTOK, M., MOLYNEUX, C.S., NEWBOLD, C.I., and MARSH, K. (1998). Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4, 358-360.
8. BURTON, D.R. (2002). Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2, 706-713.
9. CASTLE, L.A., SIEHL, D.L., GORTON, R., PATTEN, P.A., CHEN, Y.H., BERTAIN, S., CHO, H.J., DUCK, N. WONG, J., LIU, D., and LASSNER, M.W. (2004). Discovery and directed evolution of a glyphosate tolerance gene. Science 304, 1151-1154.
10. CHANG, C.C., CHEN, T.T., COX, B.W., DAWES, G.N., STEMMER, W.P., PUNNONEN, J., and PATTEN, P.A. (1999). Evolution of a cytokine using DNA family shuffling. Nat. Biotechnol. 17, 793-797.
11. CHEN, Q., FERNANDEZ, V., SUNDSTROM, A., SCHLICHTHERLE, M., DATTA, S., HAGBLOM, P., and WAHLGREN, M. (1998). Developmental selection of var gene expression in Plasmodium falciparum. Nature 394, 392-395.
12. CRAMERI, A., RAILLARD, S.A., BERMUDEZ, E., and STEMMER, W.P. (1998). DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391, 288-291.
13. DU, X., XU, L., ZHANG, W., PARREN, P., ZWICK, M., BURTON, D., and WHALEN, R. (2003). Creating novel HIV-1 gp120 and gp120 core molecules sharing similar antigenicity to native trimeric envelope complex using DNA shuffling technology. 10th Conference on Retroviruses and Opportunistic Infections, February 10-14, 2003, Boston, MA.
14. FERGUSON, N.M., GALVANI, A.P., and BUSH, R.M. (2003). Ecological and immunological determinants of influenza evolution. Nature 422, 428-433.
15. FOX, R., ROY, A, GOVINDARAJAN, S., MINSHULL, J., GUSTAFSSON, C., JONES, J.T., and EMIG, R. (2003). Optimizing the search algorithm for protein engineering by directed evolution. Protein Eng. 16, 589-597.
16. GALINSKI, M.R., and CORREDOR, V. (2004). Variant antigen expression in malaria infections: Posttranscriptional gene silencing, virulence and severe pathology. Mol. Biochem. Parasitol. 134, 17-25.
17. GIBBS, M.D., NEVALAINEN, K.M., and BERGQUIST, P.L. (2001). Degenerate oligonucleotide gene shuffling (DOGS): A method for enhancing the frequency of recombination with family shuffling. Gene 271, 13-20.
18. HAHN, Y.S. (2003). Subversion of immune responses by hepatitis C virus: Immunomodulatory strategies beyond evasion? Curr. Opin. Immunol. 15, 443-449.
19. JERMUTUS, L., HONEGGER, A., SCHWESINGER, F., HANES, J., and PLUCKTHUN, A. (2001). Tailoring in vitro evolution for protein affinity or stability. Proc. Natl. Acad. Sci. USA 98, 75-80.
20. JOERN, J.M., MEINHOLD, P., and ARNOLD, F.H. (2002). Analysis of shuffled gene libraries. J. Mol. Biol. 316, 643-656.
21. KIM, J.J., YANG, J.S., DANG, K., MANSON, K.H., and WEINER, D.B. (2001). Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants. Clin. Cancer Res. 7, 882s-889s.
22. KORBER, B., GASCHEN, B., YUSIM, K., THAKALLAPALLY, R., KESMIR, C., and DETOURS, V. (2001). Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58, 19-42.
23. KURTZMAN, A.L., GOVINDARAJAN, S., VAHLE, K., JONES, J.T., HEINRICHS, V., and PATTEN, P.A. (2001). Advances in directed protein evolution by recursive genetic recombination: Applications to therapeutic proteins. Curr. Opin. Biotechnol. 12, 361-370.
24. LAZETIC, S., LEONG, S.R., CHANG, J.C., ONG, R., DAWES, G., and PUNNONEN, J. (2002). Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells. J. Biol. Chem. 277, 38660-38668.
25. LEONG, S.R., CHANG, J.C., ONG, R., DAWES, G., STEMMER, W.P., and PUNNONEN, J. (2003). Optimized expression and specific activity of IL-12 by directed molecular evolution. Proc. Natl. Acad. Sci. USA 100, 1163-1168.
26. LOCHER, C.P., APT, D., HEINRICHS, V., and WHALEN, R.G. (2004a). Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening strategies. Expert Opin. Biol. Ther. 4, 589-597.
27. LOCHER, C.P., SOONG, N.W. WHALEN, R., and PUNNONEN, J. (2004b). Development of novel vaccines using DNA shuffling and screening strategies. Curr. Opin. Mol. Ther. 6, 34-39.
28. LOCHER, C.P., HEINRICHS, V., BASS, S., MUNDORFF, E., GADUH, A., MILLER, L.H., SAUL, A.J., LONG, C.E., WILLIAMS, N., GRATEPANCHE, S., LIU, X., et al. (2004c). DNA shuffling of Plasmodium falciparum erythrocyte membrane antigen-1 genes yields multiple variants that induce broadly cross reactive antibodies. Molecular approaches to malaria 2004. Lorne, Australia. Exp. Parasitol. 105, 52.
29. LUTZ, S., OSTERMEIER, M., MOORE, G.L., MARANAS, C.D., and BENKOVIC, S.J. (2001). Creating multiple-crossover DNA libraries independent of sequence identity. Proc. Natl. Acad. Sci. USA 98, 11248-11253.
30. MAHESHRI, N., and SCHAFFER, D.V. (2003). Computational and experimental analysis of DNA shuffling. Proc. Natl. Acad. Sci. USA 100, 3071-3076.
31. MILLER, L.H., BARUCH, D.I., MARSH, K., and DOUMBO, O.K. (2002). The pathogenic basis of malaria. Nature 415, 673-679.
32. MINSHULL, J., and STEMMER, W.P. (1999). Protein evolution by molecular-breeding. Curr. Opin. Chem. Biol. 3, :284-290.
33. MOORE, G.L., MARANAS, C.D., LUTZ, S., and BENKOVIC, S.J. (2001). Predicting crossover generation in DNA shuffling. Proc. Natl. Acad. Sci. USA 98, 3226-3231.
34. NARA, P.L., GARRITY, R.R., and GOUDSMIT, J. (1991). Neutralization of HIV-1: A paradox of humoral proportions. FASEB J. 5, 2437-2455.
35. NESS, J.E., KIM, S., GOTTMAN, A., PAK, R., KREBBER, A., BORCHERT, T.V., GOVINDARAJAN, S., MUNDORFF, E.G., and MINSHULL, J. (2002). Synthetic shuffling expands functional protein diversity by allowing amino acids to recombine independently. Nat. Biotechnol. 20, 1251-1255.
36. OBARO, S.K. (2002). The new pneumococcal vaccine. Clin. Microbiol. Infect. 8, 623-633.
37. PAIDHUNGAT, M., GOLDMAN, S., LATHROP, S., PATEL, P., DUPUY, L., SINES, H., FONG, S., SCHMALJOHN, C., PARMLEY, S., PUNNONEN, J., WHALEN, R.G., and LOCHER, C.P. (2004). Development of a novel vaccines using DNA shuffling/screening strategies and Bacillus spore display. In Bioterrorism and Emerging-Infectious Diseases: Anti-microbials, Therapeutics, and Immune-Modulators. Keystone Symposium, Keystone, CO.
38. PATTEN, P.A., HOWARD, R.J., and STEMMER, W.P. (1997). Applications of DNA shuffling to pharmaceuticals and vaccines. Curr. Opin. Biotechnol. 8, 724-733.
39. RANDALL, R., and MILLS, J.W. (1944). Fatal encephalitis in man due to the Venezuelan virus of equine encephalomyelitis in Trindad. Science 99, 225-226.
40. SCHERF, A., HERNANDEZ-RIVAS, R., BUFFET, P., BOTTIUS, E., BENATAR, C., POUVELLE, B., GYSIN, J., and LANZER, M. (1998). Antigenic variation in malaria: In situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J. 17, 5418-5426.
41. SIN, J.I., KIM, J., CHATTERGOON, M., AYYAVOO, V., MCCALLUS, D., UGEN, K.E., BOYER, J.D., and WEINER, D.B. (2000). Engineering of DNA vaccines using molecular adjuvant plasmids. Dev. Biol. (Basel) 104, 187-198.
42. SMITH, J.F., DAVIS, K., HART, M.K., LUDWIG, G.V., MCCLAIN, D.J., PARKER, M.D., and PRATT, W.D. (1997). Viral encephalitides. In Medical Aspects of Chemical and biological Warfare. F.R. Sidell, E.T. Takafuji, D.R. Franz, eds. Office of the Surgeon General at TMM Publications, Borden Institute, Walter Reed Army Medical Center, Washington, DC.
43. STAALSOE, T., SHULMAN, C.E., BULMER, J.N., KAWUONDO, K., MARSH, K., and HVIID, L. (2004). Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363, 283-289.
44. STEMMER, W.P. (1994a). DNA shuffling by random fragmentation and reassembly: In vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. USA 91, 10747-10751.
45. STEMMER, W.P. (1994b). Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389-391.
46. STEMMER, W.P., and HOLLAND, B. (2003). Survival of the fittest molecule. Am. Sci. 91, 526-533.
47. SULLENDER, W.M. (2000). Respiratory syncytial virus genetic and antigenic diversity. Clin. Microbiol. Rev. 13, 1-15.
48. TOBIN, M.B., GUSTAFSSON, C., and HUISMAN, G.W. (2000). Directed evolution: The "rational" basis for "irrational" design. Curr. Opin. Struct. Biol. 10, 421-427.
49. TRINCHIERI, G., and SCOTT, P. (1999). Interleukin-12: Basic principles and clinical applications. Curr. Top. Microbiol. Immunol. 238, 57-78.
50. WHALEN, R.G., KAIWAR, R., SOONG, N.W., and PUNNONEN, J. (2001). DNA shuffling and vaccines. Curr. Opin. Mol. Ther. 3, 31-36.
51. WHALEN, R.G., BEARD, C., XU, L., and SBAI, H. (2003). Creation of chimeric hepatitis B virus surface antigens with novel immunogenicities using DNA shuffling and screening technologies. Falk Symposium No. 138. State of the art of hepatology: Molecular and cell biology. October 20-21, 2003, Freiburg, Germany.
52. XU, L., DU, X., ZHANG, W., TANG, S., HELLENTHAL, L., HARMS, I., BALLANTYNE, I., ROBSON, R., CHAMBERS, M., WRIN, T., PETROPOULUS, C., ZWICK, M.B., BURTON, D.R., and WHALEN, R.G. (2004). Use of directed molecular evolution to create novel HIV-1 envelope variants capable of inducing broadly neutralizing antibody responses in rabbits. DNA vaccines 2004, November 17-19, 2004, Monte Carlo, Monaco.
53. YANG, S., BRINKMAN, A., SEMYONOV, A., DAWES, G., PUNNONEN, J., and APT, D. (2002). Antibody responses in mice immunized with shuffled tetravalent dengue antigens. American Society for Tropical Medicine and Hygiene 51st Annual Meeting, November 10-14, 2002, Denver, CO.
54. YOUNG, D., HUSSELL, T., and DOUGAN, G. (2002). Chronic bacterial infections: Living with unwanted guests. Nat. Immunol. 3, 1026-1032.
55. ZHANG, J.H., DAWES, G., and STEMMER, W.P. (1997). Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc. Natl. Acad. Sci. USA 94, 4504-1509.